Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

NCT06531018 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Immune Thrombocytopenia

Interventions

DRUG: Eltrombopag 25 MG
DRUG: Prednisolone

Sponsor

Renata PLC